Downloadable Slides

Share

Program Content

Activities

  • ADC Safety in mBC
    Maximizing Safety and Efficacy of ADCs in Patients With HER2-Low or Ultralow mBC
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 20, 2025

    Expires: November 19, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.